Herriot Tabuteau, CEO: Axsome Therapeutics AXSM Planned sale · Filed 01/05

Trade details

Type: Planned sale notice
Stock: Axsome Therapeutics AXSM
Person: Herriot TabuteauCEO
Planned sale date: 26/01/05
Filed: 26/01/05

More to sell after $38.9M in 3 months

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

Herriot Tabuteau's recent trades

Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$979.2K
4,660 sh
$979.2K
Filed 08/06
Traded 08/06
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$9.6M
45,004 sh
$9.6M
Filed 08/05
Traded 08/05
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12M
49,666 sh
$12M
Filed 07/01
Traded 07/01
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12.2M
49,670 sh
$12.2M
Filed 06/09
Traded 06/09
Herriot TabuteauCEO
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$12M
49,670 sh
$12M
Filed 06/09
Traded 06/09

Herriot Tabuteau, CEO — plans to sell 78,703 sh of Axsome Therapeutics AXSM · $13.5M · around 01/05 | Whalegun